| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7466392
[patent_doc_number] => 20040198716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Cysteine protease inhimbitors'
[patent_app_type] => new
[patent_app_number] => 10/467105
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11735
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198716.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467105
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467105 | Cysteine protease inhimbitors | May 16, 2004 | Abandoned |
Array
(
[id] => 7447438
[patent_doc_number] => 20040186095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Highly purified and crystalline form of harringtonines their process of preparation by purification of crude alkaloids from natural synthetic or semi-synthetic sources allowing their use for blending in pharmaceutical composition particularly useful for treatment of cancer in using oral mode of administration'
[patent_app_type] => new
[patent_app_number] => 10/472299
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4563
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186095.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472299
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472299 | Highly purified and crystalline form of harringtonines their process of preparation by purification of crude alkaloids from natural synthetic or semi-synthetic sources allowing their use for blending in pharmaceutical composition particularly useful for treatment of cancer in using oral mode of administration | May 10, 2004 | Abandoned |
Array
(
[id] => 274290
[patent_doc_number] => 07560455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-14
[patent_title] => '3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/556805
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17465
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/560/07560455.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556805 | 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | May 9, 2004 | Issued |
Array
(
[id] => 7434997
[patent_doc_number] => 20040266754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-carboxamide and optically enriched mixtures thereof'
[patent_app_type] => new
[patent_app_number] => 10/842726
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3694
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266754.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842726
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842726 | Method for racemization of (S)-(+)- and (R)-(−)-10,11-dihydro-10-hydroxy-5h-dibenz[B,F]azepine-5-carboxamide and optically enriched mixtures thereof | May 9, 2004 | Issued |
Array
(
[id] => 7329982
[patent_doc_number] => 20040254174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Method for isolating (R)-tofisopam'
[patent_app_type] => new
[patent_app_number] => 10/841075
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7712
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254174.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841075 | Method for isolating (R)-tofisopam | May 6, 2004 | Issued |
Array
(
[id] => 383130
[patent_doc_number] => 07307082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-11
[patent_title] => 'Heterocyclic derivatives as CRF antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/839323
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18376
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/307/07307082.pdf
[firstpage_image] =>[orig_patent_app_number] => 10839323
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/839323 | Heterocyclic derivatives as CRF antagonists | May 3, 2004 | Issued |
Array
(
[id] => 7351696
[patent_doc_number] => 20040248877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/837220
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13432
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248877.pdf
[firstpage_image] =>[orig_patent_app_number] => 10837220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/837220 | Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof | Apr 29, 2004 | Abandoned |
Array
(
[id] => 7297342
[patent_doc_number] => 20040214812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => '4-Substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/834301
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51156
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214812.pdf
[firstpage_image] =>[orig_patent_app_number] => 10834301
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/834301 | 4-substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as β-lactamase inhibitors | Apr 27, 2004 | Issued |
Array
(
[id] => 415387
[patent_doc_number] => 07279572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-09
[patent_title] => 'Process for the 2-stage synthesis of hexanitrohexaazaisowurtzitane starting from a primary amine'
[patent_app_type] => utility
[patent_app_number] => 10/833025
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4868
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/279/07279572.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833025
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833025 | Process for the 2-stage synthesis of hexanitrohexaazaisowurtzitane starting from a primary amine | Apr 27, 2004 | Issued |
Array
(
[id] => 526579
[patent_doc_number] => 07183271
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-27
[patent_title] => '4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof'
[patent_app_type] => utility
[patent_app_number] => 10/554150
[patent_app_country] => US
[patent_app_date] => 2004-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20667
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/183/07183271.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554150
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554150 | 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof | Apr 25, 2004 | Issued |
Array
(
[id] => 880548
[patent_doc_number] => 07355042
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-08
[patent_title] => 'Treatment of CNS disorders using CNS target modulators'
[patent_app_type] => utility
[patent_app_number] => 10/831553
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 50699
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/355/07355042.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831553
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831553 | Treatment of CNS disorders using CNS target modulators | Apr 22, 2004 | Issued |
Array
(
[id] => 7435496
[patent_doc_number] => 20040266799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'CRF receptor antagonists and methods relating thereto'
[patent_app_type] => new
[patent_app_number] => 10/830416
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7691
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266799.pdf
[firstpage_image] =>[orig_patent_app_number] => 10830416
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/830416 | CRF receptor antagonists and methods relating thereto | Apr 21, 2004 | Abandoned |
Array
(
[id] => 5142490
[patent_doc_number] => 20070004706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'New polymorphs of olanzapine hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 10/553908
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5172
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004706.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553908
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553908 | Polymorphs of olanzapine hydrochloride | Apr 21, 2004 | Issued |
Array
(
[id] => 5859882
[patent_doc_number] => 20060229302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Tricyclic indole derivatives and their use in the treatment of alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 10/553878
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24842
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553878
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553878 | Tricyclic indole derivatives and their use in the treatment of alzheimer's disease | Apr 20, 2004 | Abandoned |
Array
(
[id] => 239630
[patent_doc_number] => 07592347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Piperazine derivates and their use for the treatment of neurological and psychiatric diseases'
[patent_app_type] => utility
[patent_app_number] => 10/553803
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29161
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/592/07592347.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553803
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553803 | Piperazine derivates and their use for the treatment of neurological and psychiatric diseases | Apr 20, 2004 | Issued |
Array
(
[id] => 7468117
[patent_doc_number] => 20040198976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Method for synthesizing pyrazolobenzodiazepines'
[patent_app_type] => new
[patent_app_number] => 10/827667
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15683
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198976.pdf
[firstpage_image] =>[orig_patent_app_number] => 10827667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/827667 | Method for synthesizing pyrazolobenzodiazepines | Apr 18, 2004 | Issued |
Array
(
[id] => 7351715
[patent_doc_number] => 20040248880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => '1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position'
[patent_app_type] => new
[patent_app_number] => 10/822586
[patent_app_country] => US
[patent_app_date] => 2004-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10284
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10822586
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/822586 | 1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position | Apr 11, 2004 | Abandoned |
Array
(
[id] => 121737
[patent_doc_number] => 07709470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => '11-phenyl-dibenzodiazepine derivatives as RXR-antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/550776
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13558
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709470.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550776
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550776 | 11-phenyl-dibenzodiazepine derivatives as RXR-antagonists | Apr 7, 2004 | Issued |
Array
(
[id] => 7061718
[patent_doc_number] => 20050004080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/820216
[patent_app_country] => US
[patent_app_date] => 2004-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11714
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004080.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820216 | Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof | Apr 6, 2004 | Issued |
Array
(
[id] => 7061717
[patent_doc_number] => 20050004079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/820215
[patent_app_country] => US
[patent_app_date] => 2004-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11032
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820215
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820215 | Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof | Apr 6, 2004 | Abandoned |